RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Conditions
Neoplasms, Arteriovenous Malformation of Central Nervous System, Trigeminal NeuralgiaSummary
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Detailed Description
The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include:
Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments
The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions.
The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms.
Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.
Locations
2 locations Found with status Recruiting
Status
- RECRUITING
Contact Person
- Celina Kirsch, P.A.
- 313-640-2345
- [email protected]
Study Director
- Anand Mahadevan, MD
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
Exclusion Criteria:
* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
Study Plan
Patients being treated by SRS/SBRT
Patients with a condition being considered for treatment by SRS/SBRT
RADIATION:
SRS/SBRTDescription:
Intervention varies by condition being treated.
Outcome Measures
Primary Outcome Measures
Overall survival
Secondary Outcome Measures
Local and distant recurrence
Timeline
Last Updated
September 19, 2024Start Date
June 24, 2013Today
February 5, 2025Completion Date ( Estimated )
December 1, 2030
Sponsors of this trial
Lead Sponsor
The Radiosurgery SocietyCollaborating Sponsors
VisionTree